Eterna Therapeutics Inc. (ERNA)
ERNA Stock Price Chart
Explore Eterna Therapeutics Inc. interactive price chart. Choose custom timeframes to analyze ERNA price movements and trends.
ERNA Company Profile
Discover essential business fundamentals and corporate details for Eterna Therapeutics Inc. (ERNA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
29 Aug 1991
Employees
6.00
Website
https://www.brooklynitx.comCEO
Sanjeev Luther
Description
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy technology for the treatment of oncology, blood disorder, and monogenic disease. Brooklyn ImmunoTherapeutics, Inc. is based in Brooklyn, New York.
ERNA Financial Timeline
Browse a chronological timeline of Eterna Therapeutics Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 May 2026
Upcoming earnings on 10 Nov 2025
Earnings released on 13 Aug 2025
EPS came in at -$0.61 .
Stock split effective on 12 Jun 2025
Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 7 May 2025
EPS came in at -$2.25 .
Earnings released on 12 Mar 2025
EPS came in at -$1.14 , while revenue for the quarter reached $1.00K .
Earnings released on 12 Nov 2024
EPS came in at -$4.92 , while revenue for the quarter reached $487.00K .
Earnings released on 13 Aug 2024
EPS came in at -$1.02 , while revenue for the quarter reached $47.00K .
Earnings released on 14 May 2024
EPS came in at -$1.23 , while revenue for the quarter reached $47.00K .
Earnings released on 14 Mar 2024
EPS came in at -$1.14 , while revenue for the quarter reached $17.00K .
Earnings released on 13 Nov 2023
EPS came in at -$1.03 , while revenue for the quarter reached $51.00K .
Earnings released on 11 Aug 2023
EPS came in at -$0.85 .
Earnings released on 11 May 2023
EPS came in at -$1.06 .
Earnings released on 20 Mar 2023
EPS came in at -$1.24 .
Earnings released on 14 Nov 2022
EPS came in at -$2.49 falling short of the estimated -$2.20 by -13.18%.
Stock split effective on 17 Oct 2022
Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 11 Aug 2022
EPS came in at -$1.20 surpassing the estimated -$2.60 by +53.85%.
Earnings released on 1 Jul 2022
EPS came in at -$3.40 falling short of the estimated -$2.80 by -21.43%.
Earnings released on 31 Dec 2021
EPS came in at -$3.25 .
Earnings released on 9 Nov 2021
EPS came in at -$2.20 falling short of the estimated -$1.60 by -37.50%.
Earnings released on 13 Aug 2021
EPS came in at -$4.75 .
Earnings released on 17 May 2021
EPS came in at -$12.74 .
Stock split effective on 26 Mar 2021
Shares were split 1 : 2 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 11 Mar 2021
EPS came in at -$1.60 .
Earnings released on 11 Nov 2020
EPS came in at -$0.97 .
ERNA Stock Performance
Access detailed ERNA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.